Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: The multi-ethnic study of atherosclerosis (MESA)

Diabetes

Volumn 58, Issue 4, 2009, Pages 813-819

  Katz, Ronit ^a   Budoff, Matthew J ^b   Takasu, Junichiro ^b   Shavelle, David M ^b   Bertoni, Alain ^c   Blumenthal, Roger S ^d   Ouyang, Pamela ^d   Wong, Nathan D ^e   O'Brien, Kevin D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c WAKE FOREST UNIVERSITY   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE; AORTA VALVE CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; CALCIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CONTINENTAL POPULATION GROUPS; DISEASE PROGRESSION; ETHNIC GROUPS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; QUESTIONNAIRES; SMOKING; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 64649096899     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1515     Document Type: Article

References (53)

1. Grundy SM, Cleeman I, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005
2. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 365:1415-1428, 2005
3. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
4. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782-787, 2001
5. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200, 2001
6. AradY, Newstein D, Cadet F, Roth M, Guerci AD: Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomo- graphic study. Arterioscler Thromb Vasc Biol 21:2051-2058, 2001
7. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, Hachamovitch R, Friedman JD, Hayes S, Berman DS: The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 41:1547-1553, 2003
8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
9. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuom- ilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
10. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes JIII: Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 55:33-50, 1961
11. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29:630-634, 1997
12. Otto CM, Pearlman AS: Doppler echocardiography in adults with symptomatic aortic stenosis. Diagnostic utility and cost-effectiveness. Arch Intern Med 148:2553-2560, 1988
13. Carabello BA: Clinical practice. Aortic stenosis. N Engl J Med 346:677-682, 2002
14. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142-147, 1999
15. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, Kraft CD, Miyake-Hull CY, Schwaegler RG: Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 95:2262-2270, 1997
16. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ, O'Brien KD: Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113:2113-2119, 2006
17. Briand M, Lemieux I, Dumesnil JG, Mathieu P, Cartier A, Despres JP, Arsenault M, Couet J, Pibarot P: Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 47:2229-2236, 2006
18. Briand M, Pibarot P, Despres JP, Voisine P, Dumesnil JG, Dagenais F, Mathieu P: Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 114:I512-I517, 2006
19. Bild DE, Bluemke DA, Burke GL, Detrano R, ez Roux AV, Folsom AR,Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson C, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP: Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 156:871-881, 2002
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
21. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA 285:2486-2497, 2001
22. Budoff MJ, Mao S, Takasu J, Shavelle DM, Zhao XQ, O'Brien KD: Repro-ducibility of electron-beam CT measures of aortic valve calcification. Acad Radiol 9:1122-1127, 2002
23. Budoff MJ, Takasu J, Katz R, Mao S, Shavelle DM, O'Brien KD, Blumenthal RS, Carr J, Kronmal R: Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the Multi-Ethnic Study of Atherosclerosis. Acad Radiol 13:166-172, 2006
24. Budoff MJ, Katz R, Wong ND, Nasir K, Mao SS, Takasu J, Kronmal R, Detrano RC, Shavelle DM, Blumenthal RS, O'Brien KD, Carr JJ: Effect of scanner type on the reproducibility of extracoronary measures of calcification: the Multi-Ethnic Study of Atherosclerosis. Acad Radiol 14:10431049, 2007
25. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832, 1990
26. Martin RD: Robust Statistics With the S-Plus Robust Library and Financial Applications. New York: Insightful; 2002
27. Venables WN, Ripley BD: Modern Applied Statistics With S-Plus. New York: Springer; 1999:167-176
28. Boon A, Cheriex E, Lodder J, Kessels F: Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 78:472-474, 1997
29. Aronow WS, Schwartz KS, Koenigsberg M: Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am, J Cardiol 59:998-999, 1987
30. Aronow WS, Ahn C, Kronzon I, Goldman ME: Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 88:693-695, 2001
31. Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, Hofmann SM, Vlassara H, Shi Y: Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 108:472-478, 2003
32. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA: MSX2 promotes osteogenesis and suppresses adipogenic differentiation of mul- tipotent mesenchymal progenitors. J Biol Chem 278:45969-45977, 2003
33. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800-1809, 1993
34. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL: TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93:2106-2113, 1994
35. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS: Bone formation and inflammation in cardiac valves. Circulation 103:1522-1528, 2001
36. Wozney JM, Rosen V: Bone morphogenetic protein and bone morphoge- netic protein gene family in bone formation and repair. Clin Orthop Relat Res 346:26-37, 1998
37. Baynes JW, Thorpe SR: Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716, 2000
38. Pennathur S, Wagner JD, Leeuwenburgh C, Litwak KN, Heinecke JW: A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in earlydiabetic vascular disease. JClinInvest 107:853-860, 2001
39. Olsson M, Thyberg J, Nilsson J: Presence of oxidized low density lipopro- tein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 19:1218-1222, 1999
40. Mohler ER III, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH: Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 8:254-260, 1999
41. Owens DS, Katz R, Johnson E, Shavelle DM, Probstfield JL, Takasu J, Crouse JR, Carr JJ, Kronmal R, Budoff MJ, O'Brien KD: Interaction of age with lipoproteins as predictors of aortic valve calcification in the MultiEthnic Study of Atherosclerosis. Arch Intern Med 168:1200-1207, 2008
42. Tannock LR, O'Brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, Kahn SE, Chait A: Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 111:30583062, 2005
43. Novaro GM, Tiong Y, Pearce GL, Lauer MS, Sprecher DL, Griffin BP: Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 104:2205-2209, 2001
44. Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, Daniel WG,Achenbach S: Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104:1927-1932, 2001
45. Shavelle DM, Takasu J, Budoff MJ, Mao S, O'Brien KD: HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 359:11251126, 2002
46. Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper M,Binder T, Maurer G, Baumgartner H: Statins but not angiotensin-convert-ing enzyme inhibitors delay progression of aortic stenosis. Circulation 110:1291-1295, 2004
47. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA: A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352:2389-2397, 2005
48. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R: Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359:13431356, 2008
49. O'Brien KD, Shavelle DM, Caulfield MT, McDonald TO, Olin-Lewis K, Otto CM, Probstfield JL: Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106:2224-2230, 2002
50. O'Brien KD, Probstfield JL, Caulfield MT, Nasir K, Takasu J, Shavelle DM, Wu AH, Zhao XQ, Budoff MJ: Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 165:858-862, 2005
51. Helske S, Lindstedt KA, Laine M, Mayranpaa M, Werkkala K, Lommi J, Turto H, Kupari M, Kovanen PT: Induction of local angiotensin II- producing systems in stenotic aortic valves. J Am, Coll Cardiol 44:18591866, 2004
52. Arishiro K, Hoshiga M, Negoro N, Jin D, Takai S, Miyazaki M, Ishihara T, Hanafusa T: Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholester- olemic rabbits. J Am Coll Cardiol 49:1482-1489, 2007
53. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:15771589, 2008